Healthcare · Health Information Services · NASDAQ

Privia Health Group Inc (PRVA) Stock Price, Analysis & Trade Signals

$24.55+0.88 (+3.72%)

Privia Health Group, Inc. functions as a national entity focused on empowering physicians throughout the United States. It partners with medical groups, health plans, and health systems, with the primary objective of optimizing physician practices, enhancing patient experiences, and appropriately compensating clinicians for care delivered both virtually and in person. To achieve this, Privia offers a comprehensive suite of services. These include technology and population health tools designed to streamline independent providers' workflows; a Management Services Organization (MSO) that…

PRVA key stats

Market Cap
$3.14B
P/E Ratio
94.42
Forward P/E
24.45
EPS
0.26
52 Week Range
$18.92 – $28.82
50-Day Avg
21.40
200-Day Avg
22.67
Revenue (TTM)
$2.43B
Revenue Growth (Qtr YoY)
13.2%
Profit Margin
1%
Operating Margin (TTM)
2.1%
Beta
0.75
Volume
1.61M
30-Day Avg Volume
1.32M
CEO
Parth Mehrotra
Employees
1,226
IPO Date
Apr 28, 2021

PRVA analyst rating & price target

18 analysts rate PRVA Buy on consensus.

5Strong Buy
12Buy
1Hold
0Sell
0Strong Sell

Consensus price target: $31.35 (+27.7% upside from $24.55)

Recent PRVA insider transactions

InsiderDateTransactionSharesValue
Mountcastle David
EVP & Chief Financial Officer
Jul 7, 2026Sale600$16.54K
Morris Matthew Shawn
director
Jul 1, 2026Sale45,634$1.21M
Morris Matthew Shawn
director
Jul 1, 2026Sale37,041$997.51K
Morris Matthew Shawn
director
Jun 30, 2026Sale52,823$1.36M
Mehrotra Parth
director, Chief Executive Officer
May 12, 2026Sale15,647$354.25K

Privia Health Group Inc annual revenue & net income

Fiscal yearRevenueRevenue YoYNet income
2025$2.12B+22.26%$22.92M
2024$1.74B+4.74%$14.39M
2023$1.66B+22.19%$23.08M

Latest PRVA news

Stock data for PRVA: Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics